Skip to content

A study of Homoeopathic remedy Arsenicum iodatum for Allergy related sneezing and running nose in children

A controlled clinical study on the effectiveness of Arsenicum iodatum in LM potency in managing Allergic Rhinitis among Paediatric age group - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093509
Enrollment
60
Registered
2025-08-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Arsenicum iodatum in 50 millesimal scale potency: Potency- 50 Millesimal potency for 2 months Dose - Homoeopathic medicines will be administered orally according to the susceptiblity o

Sponsors

Sarada Krishna Homoeopathic Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children and adolescents aged between 2 and 18 years Both male and female participants Diagnosis primarily determined by clinical symptoms Individuals experiencing repeated episodes of allergic rhinitis Evaluation of improvement based on the reduction of symptoms

Exclusion criteria

Exclusion criteria: Patients with additional respiratory disorders or associated complications. Patients suffering from other severe systemic diseases.

Design outcomes

Secondary

MeasureTime frame
Disappearance of symptoms will be noted.Timepoint: 2 months;General Improvement of the patient will be notedTimepoint: 2 months

Primary

MeasureTime frame
Significant reduction in the symptom severity assessed using the Total Nasal Symptom Severity (TNSS) Score in the intervention group compared to the baseline.Timepoint: 2 months

Countries

India

Contacts

Public ContactDr P R Sisir

Sarada Krishna Homoeopathic Medical College

hodpd@skhmc.org9443474941

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026